Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers
Liliana Mâncio-Silva(Centre National de la Recherche Scientifique), Sangeeta N. Bhatia(Massachusetts Institute of Technology), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Patrick Haslett, Heather E. Fleming(Massachusetts Institute of Technology), Stuart Milstein(Alnylam Pharmaceuticals (United States)), Abigail Liebow(Alnylam Pharmaceuticals (United States)), A. B. Miller(Broad Institute)
Cited by 16
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Therapeutic siRNA silencing in inflammatory monocytes in mice
|Nature Biotechnology|2011|837
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409